
Sais e Derivados de API
Os sais dos Ingredientes Farmacêuticos Ativos (API) são compostos formados pela reação de um ácido com uma base, resultando em um equilíbrio iônico. Esses sais frequentemente melhoram a solubilidade e a estabilidade dos APIs, facilitando sua absorção no organismo. Os derivados de API são variantes químicas de um princípio ativo que podem apresentar propriedades aprimoradas ou modificadas para otimizar a eficácia terapêutica. Os sais de APIs são utilizados na formulação de medicamentos orais, injetáveis e tópicos. Além disso, os derivados de API podem melhorar a farmacocinética dos fármacos, permitindo, por exemplo, a liberação controlada de substâncias ativas.
Na CymitQuimica, oferecemos sais e derivados de APIs com a pureza e qualidade necessárias para pesquisa e desenvolvimento de formulações farmacêuticas.
Foram encontrados 79376 produtos de "Sais e Derivados de API"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
10-Hydroxy Warfarin(Mixture of Diastereomers)
CAS:Produto ControladoFórmula:C19H16O5Cor e Forma:NeatPeso molecular:324.33Diclofenac Dimer Impurity
CAS:<p>Applications Diclofenac Dimer Impurity, is an metabolite of Diclofenac (D436450), which is nonsteroidal anti-inflammatory compound acting as decycloxygenase (COX) inhibitor.<br>References Kenny, J. R., et al.: J. Med. Chem., 47, 2816 (2004), Sasaki, A., et al.: J. Pharmacol. Sci., 108, 266 (2008), Dalvie, D., et al.: Chem. Res. Toxicol., 22, 357 (2009),<br></p>Fórmula:C28H20Cl4N2O4Cor e Forma:Light Orange Colour To RedPeso molecular:590.28Potassium Thiocyanate
CAS:Produto Controlado<p>Applications Potassium Thiocyanate has been used as a catalyst in a one-pot reaction of dialkyl acetylenedicarboxylates with indane-1,3-dione. Potassium Thiocyanate has been used as a selective bacterial inhibitor to create ESS-3 broth to allow co-enrichment of the target pathogens and suppress growth of some non-target pathogens<br>References Hassanabadi, A., Zhiani, R., et. al.: J. Chem. Res., 37, 458 (2013); Zhang, Q., et. al.: Plant. Biotech., 29, 103 (2012)<br></p>Fórmula:CKNSCor e Forma:WhitePeso molecular:97.18Dofetilide-d4
CAS:Produto Controlado<p>Applications Potassium channel blocker.<br>References Carmeliet, D., et al.: J. Pharmacol. Exp. Ther., 262, 809 (1992), Norgaard, B.L., et al.: Am. Heart J., 137, 1062 (1999), Torp-Pedersen, C., et al.: N. Engl. J. Med. 341, 857 (1999)<br></p>Fórmula:C19H23D4N3O5S2Cor e Forma:NeatPeso molecular:445.59Mivacurium Chloride (mixture of isomers)
CAS:Produto ControladoFórmula:C58H80N2O14·2ClCor e Forma:NeatPeso molecular:1100.17N-(R)-Glycidyl Phthalimide
CAS:Produto Controlado<p>Applications Reagent used for the simultaneous preparation of amino alcohol solvating agents as well as preparation of orally available anticoagulants.<br>References Roehrig, S. et al: J. Med. Chem., 48, 5900 (2005); Bozkurt, S. et al: Tetra: Asymm., 22, 541 (2011);<br></p>Fórmula:C11H9NO3Cor e Forma:NeatPeso molecular:203.19(R)-6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone
CAS:Produto Controlado<p>Applications A metabolite of Levosimendan.<br>References Rubinstein, A., et al.: J. Pharmacol. Met., 19, 213 , (1988), Pollesello, P., et al.: J. Biol. Chem., 269, 28584 (1994), Yokoshiki, H., et al.: Eur. J. Pharmacol., 333, 249 (1997)<br></p>Fórmula:C11H13N3OCor e Forma:NeatPeso molecular:203.24Apixaban PG Ester-II
CAS:Produto Controlado<p>Applications Apixaban PG Ester-II is one of the multiple constituents extracted from Biebersteinia multifida, that exhibits inhibitory activity on acetylcholinesterase.<br>References Xiang, F., et al.: Faming Zhuanli Shenqing (2019), CN 109432093 A 20190308.<br></p>Fórmula:C28H30N4O6Cor e Forma:NeatPeso molecular:518.56R-(+)-Warfarin-d5
CAS:Produto Controlado<p>Applications R-(+)-Warfarin-d5 is the isotope labelled analog of R-(+)-Warfarin, an enantiomer of Warfarin (W498500). Coumarin anticoagulant.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Hagan, E.C., et al.: J. Am. Pharm. Assoc. Sci. Ed., 42, 379 (1953), Bell, R.G., et al.: Biochemistry, 11, 1959 (1972), Valente, J.E., et al.: J. Med. Chem., 20, 1489 (1977), Back, N., et al.: Pharmacol. Res. Commun., 10, 445, (1978), Babhair, S.A., et al.: Anal. Profiles Drug Subs., 14, 423 (1985), Takahashi, H., et al.: Echizen, Clin. Pharmacokinet., 40, 587 (2001),<br></p>Fórmula:C192H5H11O4Cor e Forma:White To Off-WhitePeso molecular:313.359Probenecid Acyl β-D-Glucuronide >90%
CAS:Produto Controlado<p>Stability Hygroscopic<br>Applications The major metabolite of Probenecid (P755000).<br>References Blanckaert, N., et al.: Biochem. J., 171, 203 (1978), Worrall, S., et al.: Life Sci., 56, 1921 (1995), Presle, N., et al.: Drug Metab. Disos., 24, 1050 (1996), Akira, K., et al.: J. Pharmacol. Toxicol. Methods, 37, 237 (1997), Terrier, N., et al.: Mol. Pharmacol., 56, 226 (1999),<br></p>Fórmula:C19H27NO10SPureza:>90%Cor e Forma:NeatPeso molecular:461.485-Methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylic Acid Hydrochloride
CAS:Produto Controlado<p>Stability Hygroscopic<br>Applications 5-Methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylic Acid Hydrochloride is used as a reagent in the synthesis of N-(2-acylaminobenzyl or 2-acylaminoheterocyclylmethyl)thiophene-2-carboxamide derivatives as antithrombotics. It is also used as a reagent in the synthesis of diamide derivatives as FXa inhibitors. 5-Methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylic Acid Hydrochloride is an intermediate for Edoxaban (E555520).<br>References Mochizuki, A., et al.: Jpn. Kokai Tokkyo Koho. JP 2010120852 A 20100603. Jun 3, 2010; Mochizuki, A., et al.: PCT Int. Appl. WO 2008123017 A1 20081016. Oct 16, 2008<br></p>Fórmula:C8H11ClN2O2SCor e Forma:Light BrownPeso molecular:234.7Tolvaptan-d7
CAS:Produto Controlado<p>Applications Labelled Tolvaptan. It is a selective, competitive arginine vasopressin V2 receptor antagonist used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH).<br>References Paterna, S., et al.: Eur. J. Heart Fail, 2, 305 (2000), Udelson, J., et al.: Circulation, 104, 2417 (2001), Goldsmith, S., et al.: J. Am. Coll Cardiol., 46, 1785 (2005), Schrier, R., et al.: N. Engl. J. Med., 355, 2099 (2006),<br></p>Fórmula:C26H18D7ClN2O3Cor e Forma:NeatPeso molecular:455.98(15S)-Latanoprost
CAS:<p>Impurity Latanoprost USP Related Compound B<br>Applications An impurity of commercially prepared Latanoprost (L177280). Latanoprost USP Related Compound B.<br>References Resul, B., et al.: J. Med. Chem., 36, 2242 (1993),<br></p>Fórmula:C26H40O5Cor e Forma:ColourlessPeso molecular:432.59Hydroxy Brimonidine Trifluoroacetic Acid Salt
CAS:<p>Impurity Brimonidine EP Impurity G<br>Applications A possible metabolite of Brimonidine (B677520).<br></p>Fórmula:C11H12BrN5O·C2HF3O2Cor e Forma:NeatPeso molecular:424.1732Eltrombopag-13C4
CAS:Produto ControladoFórmula:C2113C4H22N4O4Cor e Forma:Light Yellow To Dark OrangePeso molecular:446.441,2,3,4-Tetradehydro Argatroban
CAS:Produto Controlado<p>Applications 1,2,3,4-Tetrahydro Argatroban is a metabolite of Argatroban (A769000); a synthetic thrombin inhibitor and antithrombotic.<br>References Abiko, Y., et al.: Thromb. Res., 24, 285 (1981); Kikumoto, R., et al.: Biochemistry, 23, 85 (1984)<br></p>Fórmula:C23H32N6O5SCor e Forma:NeatPeso molecular:504.60Repaglinide
CAS:Produto Controlado<p>Applications Non-sulfonylurea oral hypoglycemic agent. Used as an antidiabetic.<br>References Wolffenbuttel, B.H.R., et al.: Eur. J. Clin. Pharmacol., 45, 113 (1993), Ampudia-Blasco, F.J., et al.: Diabetologia, 37, 703 (1994),<br></p>Fórmula:C27H36N2O4Cor e Forma:White To Off-WhitePeso molecular:452.59Allopurinol-d2
CAS:Produto Controlado<p>Applications Labelled xanthine oxidase inhibitor; decreases uric acid production. Used in treatment of hyperuricemia and chronic gout. Antiurolithic.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Benezra, S.A., et al.: Anal. Profiles Drug Subs., 7, 1, (1978), Dalbeth, N., et al.: Rheumatology, 44, 1090 (2005), Dinarello, C., et al.: J. Exp. Med., 201, 1355 (2005),<br></p>Fórmula:C52H2H2N4OCor e Forma:Light BrownPeso molecular:138.12Ramiprilat Acyl-β-D-glucuronide >65%
CAS:Produto ControladoFórmula:C27H36N2O11Pureza:>65%Cor e Forma:NeatPeso molecular:564.58Valsartan Sacubitril
CAS:Fórmula:C24H28NO5C24H27N5O3Na(H20)Peso molecular:410.5 : 433.5 : 3(23.0) : 5/2(18.0)4-[(5,6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino]-1-butanol
CAS:Produto Controlado<p>Applications 4-[(5,6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino]-1-butanol is a diphenylpyrazine derivative which belongs to a class of prostacyclin receptor agonists. It is an impurity of Selexipag (S253150) that is a potential drug for the treatment of various vascular disorders such as pulmonary arterial hypertension and arteriosclerosis obliterans.<br>References Asaki, T., et al.: Bioorg. Med. Chem., 15, 6692 (2007); Kuwano, K., et al.: J. Pharm. Exp. Ther., 322, 1181 (2007);<br></p>Fórmula:C23H27N3OCor e Forma:NeatPeso molecular:361.48Probenecid-d14
CAS:Produto Controlado<p>Applications Uricosuric.<br>References McKinney, S.E., et al.: J. Pharmacol. Exp. Ther., 102, 208 (1951), Israili, Z.H., et al.: J. Med. Chem., 15, 709 (1972), Al-Badr, A.A., et al.: Anal. Profiles Drug Subs., 10, 639 (1981), Cunningham, R.F., et al.: Clin. Pharmacokinet., 6, 135 (1981),<br></p>Fórmula:C13D14H5NO4SCor e Forma:NeatPeso molecular:299.45Levosimendan
CAS:<p>Applications Bioactive enantiomer of racemate, Simendan. Positive inotropic agent with vasodilating activity. Cardiotonic.<br>References Sandell, E.-P., et al.: J. Cardiovasc. Pharmacol., 26, S57 (1995), Pagel, P.S., et al.: Cardiovasc. Drug Rev., 14, 286 (1996),<br></p>Fórmula:C14H12N6OCor e Forma:Yellow To Dark YellowPeso molecular:280.28

